Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer

Non-small cell lung cancer is the predominant type of lung cancer, resulting in high mortality worldwide. Digoxin, a cardiac glycoside, has recently been suggested to be a novel chemotherapeutic agent. Src is an oncogene that plays an important role in cancer progression and is therefore a potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Sheng-Yi, Chang, Hsiu-Hui, Lai, Yi-Hua, Lin, Ching-Hsiung, Chen, Min-Hsuan, Chang, Gee-Chen, Tsai, Meng-Feng, Chen, Jeremy J. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425490/
https://www.ncbi.nlm.nih.gov/pubmed/25955608
http://dx.doi.org/10.1371/journal.pone.0123305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425490/
https://www.ncbi.nlm.nih.gov/pubmed/25955608
http://dx.doi.org/10.1371/journal.pone.0123305

Ejemplares similares